EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Clinical management of contrast-induced neurotoxicity: a systematic review

Frederick P Mariajoseph, Jia Xi Chung, Leon T Lai, Justin Moore, Tony Goldschlager, Ronil V Chandra, Adrian Praeger, Lee-Anne Slater

Acta Neurologica Belgica · 2024-08 · 124 (4) · 1141-1149

DOI: 10.1007/s13760-024-02474-4 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Acta Neurologica Belgica, online erschienen am 08.02.2024. Verfasst von Frederick P Mariajoseph und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Monash Health, Clayton, VIC, Australia. frederick.mariajoseph@gmail.com. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Contrast Media. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Contrast-induced neurotoxicity (CIN) is an increasingly recognised complication following endovascular procedures utilising contrast. It remains poorly understood with heterogenous clinical management strategies. The aim of this review was to identify commonly employed treatments for CIN to enhance clinical decision making.

Methods

A systematic search of Embase (1947–2022) and Medline (1946–2022) was conducted. Articles describing (i) patients with a clinical diagnosis of CIN, (ii) with radiological exclusion of other pathologies, (iii) detailed report of treatments, and (iv) discharge outcomes, were included. Data relating to demographics, procedure, symptoms, treatment and outcomes were extracted.

Results

A total of 73 patients were included, with a median age of 64 years. The most common procedures were cerebral angiography (42.5%) and coronary angiography (42.5%), and the median volume of contrast administered was 150 ml. The most common symptoms were cortical blindness (38.4%) and reduced consciousness (28.8%), and 84.9% of patients experienced complete resolution at the time of discharge. Management included intravenous fluids to dilute contrast in the cerebrovasculature (54.8%), corticosteroids to reduce blood–brain barrier damage (47.9%), antiseizure (16.4%) and sedative (16.4%) medications. Mannitol (13.7%) was also utilised to reduce cerebral oedema. Intensive care admission was required for 19.2% of patients. No statistically significant differences were observed between treatment and discharge outcomes.

Conclusions

The clinical management of CIN should be considered on a patient-by-patient basis, but may consist of aggressive fluid therapy alongside corticosteroids, as well as other supportive therapy as required. Further examination of CIN management is required to define best practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurotoxicity SyndromesContrast MediaHumansEndovascular ProceduresMiddle Aged

Stichwörter der Autor:innen

Adverse eventComplicationContrastEncephalopathyEndovascularManagementNeurotoxicityTreatment

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Neurosurgery, Monash Health, Clayton, VIC, Australia. frederick.mariajoseph@gmail.com.
  • Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia. frederick.mariajoseph@gmail.com.
  • Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.
  • Department of Neurosurgery, Monash Health, Clayton, VIC, Australia.
  • Monash Imaging, Monash Health, Clayton, Melbourne, Australia.
  • Department of Radiology, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.

Förderung

  • Monash University

Zitieren

APA

Mariajoseph, F. P., Chung, J. X., Lai, L. T., Moore, J., Goldschlager, T., Chandra, R. V., Praeger, A., & Slater, L. A. (2024). Clinical management of contrast-induced neurotoxicity: a systematic review. Acta Neurologica Belgica, 124(4), 1141-1149. https://doi.org/10.1007/s13760-024-02474-4

Vancouver

Mariajoseph FP, Chung JX, Lai LT, Moore J, Goldschlager T, Chandra RV, et al. Clinical management of contrast-induced neurotoxicity: a systematic review. Acta Neurologica Belgica. 2024;124(4):1141-1149. doi:10.1007/s13760-024-02474-4

BibTeX
@article{Mariajoseph2024,
  author = {Mariajoseph, Frederick P and Chung, Jia Xi and Lai, Leon T and Moore, Justin and Goldschlager, Tony and Chandra, Ronil V and Praeger, Adrian and Slater, Lee-Anne},
  title = {Clinical management of contrast-induced neurotoxicity: a systematic review},
  journal = {Acta Neurologica Belgica},
  year = {2024},
  volume = {124},
  number = {4},
  pages = {1141--1149},
  doi = {10.1007/s13760-024-02474-4}
}
Kostenlos starten →